On August 23, 2025, Kevin Matras used a high-powered approach to close winners for Esperion Therapeutics.
1 report, 1 independent
Updated Aug 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
On August 23, 2025, Kevin Matras used a high-powered approach to close winners for Esperion Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Esperion Therapeutics
American pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksAre Options Traders Betting on a Big Move in Esperion Therapeutics Stock? Investors in Esperion Therapeutics, Inc. ESPR need to pay close attention to the stock based on moves in the options market l